Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cancer Med ; 13(7): e7162, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38572952

RESUMEN

PURPOSE: Genetic mutation detection has become an important step in nonsmall-cell lung cancer (NSCLC) treatment because of the increasing number of drugs that target genomic rearrangements. A multiplex test that can detect multiple gene mutations prior to treatment is thus necessary. Currently, either next-generation sequencing (NGS)-based or polymerase chain reaction (PCR)-based tests are used. We evaluated the performance of the Oncomine Dx Target Test (ODxTT), an NGS-based multiplex biomarker panel test, and the AmoyDx Pan Lung Cancer PCR Panel (AmoyDx PLC panel), a real-time PCR-based multiplex biomarker panel test. MATERIALS AND METHODS: Patients with histologically diagnosed NSCLC and a sufficient sample volume to simultaneously perform the AmoyDx PLC panel and ODxTT-M were included in the study. The success and detection rates of both tests were evaluated. RESULTS: Biopsies revealed 116 cases of malignancies, 100 of which were NSCLC. Of these, 59 met the inclusion criteria and were eligible for analysis. The success rates were 100% and 98% for AmoyDx PLC panel and ODxTT-M, respectively. Nine driver mutations were detected in 35.9% and 37.3% of AmoyDx PLC and ODxTT-M panels, respectively. EGFR mutations were detected in 14% and 12% of samples using the AmoyDx PLC panel and ODxTT-M, respectively. Of the 58 cases in which both NGS and AmoyDx PLC panels were successful, discordant results were observed in seven cases. These differences were mainly due to different sensitivities of the detection methods used and the gene variants targeted in each test. DISCUSSION: The AmoyDx PLC panel, a PCR-based multiplex diagnostic test, exhibits a high success rate. The frequency of the nine genes targeted for treatment detected by the AmoyDx PLC panel was comparable to the frequency of mutations detected by ODxTT-M. Clinicians should understand and use the AmoyDx PLC panel and ODxTT-M with respect to their respective performances and limitations.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas , Neoplasias Pulmonares , Humanos , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/tratamiento farmacológico , Reacción en Cadena de la Polimerasa Multiplex , Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Mutación , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Biomarcadores
2.
Artículo en Inglés | MEDLINE | ID: mdl-36767581

RESUMEN

(1) Background: Although many previous studies have found an association between burnout and emotions, none have examined the association between emotions detected by an emotion cognition system and burnout. The purpose of this study is to examine the relationship between the emotions detected by the emotion cognition system and burnout among workers. We hypothesized that burnout survivors are less likely to express their emotions as facial expressions. (2) Methods: One hundred and forty-one workers at an Information Technology (IT) products and services trading company were asked to take facial images for three months when they started and left work and responded to a burnout questionnaire once a month. Microsoft Azure was used to detect their emotions. (3) Results: Hierarchical multiple regression analyses revealed that happiness in Period 1 was significantly and negatively associated with burnout at Time 2. This association was also observed after the various covariates were included. However, burnout at Time 3 was not significantly related to any emotions in Period 1. (4) Conclusions: Happiness, as detected by the emotion cognition system, was associated with burnout immediately afterward.


Asunto(s)
Agotamiento Profesional , Felicidad , Humanos , Tecnología de la Información , Emociones , Cognición
3.
J Extracell Vesicles ; 11(3): e12205, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-35289089

RESUMEN

The development of a new large-scale purification protocol is required for research on the reliable bioactivity and drug discovery of extracellular vesicles (EVs). To address this issue, herein, we propose an effective method for preparing high-performance exosomes (EXOs) by using an anion-exchange method. Cytotoxic T-lymphocyte (CTL) EVs from 4 L of culture supernatant through a 220 nm cut-off filter are divided into two populations at a deproteinization rate of over 99.97%, which are eluted at low (0.15 M-0.3 M) and high (0.3 M-0.5 M) NaCl concentrations (approximately 2 × 1012 and 1.5 × 1012 particles, respectively) through the anion-exchange column chromatography. The former are abundant in EXO proteins, including late endosome-associated proteins and rab-family and integrin-family proteins, and functional micro (mi) RNAs, and have bioactivity for preventing tumour metastasis by depleting mesenchymal cell populations in the primary tumour lesions. By contrast, the latter is microvesicle (MV)-like particles including DNA, core histone and ribosomal proteins, and GC-rich miRNAs with unknown function, and are easily phagocytosed by mannose receptor+ Kupffer cells. Thus, the anion-exchange method is suitable for the large-scale separation of bioactive EXOs and MV-like EVs as a cargo for dangerous nucleic acids at high-purity.


Asunto(s)
Exosomas , Vesículas Extracelulares , Neoplasias , Ácidos Nucleicos , Aniones/análisis , Exosomas/genética , Vesículas Extracelulares/química , Humanos , Neoplasias/diagnóstico , Ácidos Nucleicos/análisis
4.
Cureus ; 12(10): e11184, 2020 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-33133802

RESUMEN

BACKGROUND AND PURPOSE: The Cancer Functional Assessment Set (cFAS) was developed as a scale for assessing physical function specifically for cancer patients. It is a scale that allows for accurate assessment of physical functioning and the effectiveness of rehabilitation interventions in cancer patients. Here we reported a case of the use of cFAS in rehabilitation after thoracic intradural extramedullary tumor resection. CASE DESCRIPTION: A thoracic spine magnetic resonance imaging scan showed an intradural extramedullary tumor of Th6, which was resected. Postoperatively, the patient was transferred to the recovery unit of our hospital. The residual ataxia symptoms derived from posterior cord symptoms were characteristic of this case. INTERVENTION: Using cFAS and Functional Independence Measure (FIM) as indices for evaluation, physical therapy was aimed at improving ataxic gait and occupational therapy was performed for impairment of activities of daily living. These treatments were performed for three hours a day during the hospitalization. OUTCOMES: Ataxic gait from position sense disturbance due to posterior compression of the spinal cord was present. The FIM (motor component) and cFAS at admission were 58 and 55 points, respectively. Rehabilitation was continued, and the FIM (motor component) and cFAS at discharge were 88 and 86 points, respectively, both showing improvement relative to admission. The patient was discharged 69 days after surgery. DISCUSSION: Both cFAS and FIM improved after surgery with rehabilitation, reflecting improvement in activities of daily living during recovery from position sense disturbance. Previous cFAS studies had included gastrointestinal, pulmonary, brain, hematologic, genitourinary, genitourinary, head and neck cancers. cFAS may furthermore be a useful tool for assessing spinal cord tumors, particularly in the presence of posterior cord injury.

5.
Chembiochem ; 21(4): 517-522, 2020 02 17.
Artículo en Inglés | MEDLINE | ID: mdl-31460689

RESUMEN

Spectroscopic characterization of AgI -ion-mediated C-AgI -A and C-AgI -T base pairs found in primer extension reactions catalyzed by DNA polymerases was conducted. UV melting experiments revealed that C-A and C-T mismatched base pairs in oligodeoxynucleotide duplexes are specifically stabilized by AgI ions in 1:1 stoichiometry in the same manner as a C-C mismatched base pair. Although the stability of the mismatched base pairs in the absence of AgI ions is in the order C-A≈C-T>C-C, the stabilizing effect of AgI ions follows the order C-C>C-A≈C-T. However, the comparative susceptibility of dNTPs to AgI -mediated enzymatic incorporation into the site opposite templating C is dATP>dTTP≫dCTP, as reported. The net charge, as well as the size and/or shape complementarity of the metal-mediated base pairs, or the stabilities of mismatched base pairs in the absence of metal ions, would be more important than the stability of the metallo-base pairs in the replicating reaction catalyzed by DNA polymerases.


Asunto(s)
Emparejamiento Base , ADN Polimerasa Dirigida por ADN/química , ADN , Plata/química , ADN/química , Iones , Termodinámica
6.
Case Rep Oncol ; 12(1): 147-156, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31043953

RESUMEN

INTRODUCTION: Cytokine release syndrome (CRS) is a potentially life-threatening systemic disease that has been observed after treatment with antibodies and adoptive T cell therapies. In this case, we observed nivolumab-induced CRS in a patient with gastric cancer. CASE PRESENTATION: A 43-year-old male with advanced gastric cancer was treated with nivolumab as a third-line chemotherapy. He had no history of allergies. Eight days after the first administration of nivolumab, fever, tachycardia, appetite loss and increases in liver and biliary enzymes were observed. Computed tomography revealed neither bile duct obstruction nor progression of liver metastases but showed that there was edema of the Gleason sheath. Histopathological analysis of the liver revealed cholestatic liver injury with CD8+ T lymphocyte and macrophage infiltration. Neither viral infection nor autoimmune disease was revealed. His symptoms were similar to those of CRS observed after T cell therapy. We diagnosed his disease as nivolumab-induced liver injury and cholangitis accompanied by CRS based on his serum cytokine levels. DISCUSSION/CONCLUSION: To the best of our knowledge, this is the first report of nivolumab-induced CRS in a patient with gastric cancer.

7.
Int J Clin Exp Pathol ; 12(3): 1029-1034, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31933915

RESUMEN

Nodular fasciitis (NF) is a self-limited tumorous lesion occurring in the upper as well as lower extremities. NF is composed of a proliferation of "primary culture"-like myofibroblastic cells with nuclear atypia and large nucleoli, thus mimicking sarcoma. NF harbors a promoter-swapping fusion gene containing the entire coding region of USP6 gene. Therefore, NF is a tumor with a fusion oncogene but self-limited. In order to explore why NF is self-limited, we examined whether myofibroblastic cells in NF express p16 protein, a gene product of CDKN2A gene and an inhibitor of cyclin-dependent kinase 4 (CDK4) as well as one of the hallmarks of cellular senescence. We immunohistochemically demonstrated strong and diffuse expression of p16 in myofibroblastic cells in 11 out of 15 cases of NF, and strong but partial expression in the remaining 4 of the cases. We also showed that 15 out of 15 cases of NF were immunohistochemically negative or only showed focal and faint immunopositivity for CDK4, murine double minute 2 (MDM2), and TP53 proteins. Furthermore, there were no significant changes in the copy number of CDKN2A, CDK4 and MDM2 genes, and no significant mutations in TP53, RB1, and CDKN2A genes in 1 case of NF selected. These data suggest a possible involvement in cell cycle arrest and presumed cellular senescence by p16 in myofibroblastic cells in NF. This may explain the self-limited as well as inflammatory nature of NF as a senescence-associated secretory phenotype.

8.
Oncoimmunology ; 6(5): e1306617, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28638727

RESUMEN

The CXCR3 ligands CXCL9, 10, and 11 play critical roles in the amplification of immune responses by recruiting CXCR3+ immune effector cells to the tumor site. Taking advantage of this property of CXCR3 ligands, we aimed to establish a novel approach to identify immunogenic mutated-antigens. We examined the feasibility of using CXCR3 ligand mRNAs as sensors for detection of specific immune responses in human and murine systems. We further investigated whether this approach is applicable for the identification of immunogenic mutated-antigens by using murine sarcoma lines. Rapid synthesis of CXCR3 ligand mRNAs occurred shortly after specific immune responses in both human and murine immune systems. Particularly, in CMS5 tumor-bearing mice, we detected specific immune responses to mutated mitogen-activated protein kinase 2 (ERK2), which has previously been identified as an immunogenic mutated-antigen. Furthermore, by combining this approach with whole-exome and transcriptome sequencing analyses, we identified an immunogenic neo-epitope derived from mutated staphylococcal nuclease domain-containing protein 1 (Snd1) in CMS7 tumor-bearing mice. Most importantly, we successfully detected the specific immune response to this neo-epitope even without co-administration of anti-cytotoxic T-lymphocyte protein-4 (CTLA-4), anti-programmed cell death-1 (PD-1) and anti-glucocorticoid-induced TNFR-related protein (GITR) antibodies, which vigorously augmented the immune response and consequently enabled us to detect the specific immune response to this neo-epitope by conventional IFNγ intracellular staining method. Our data indicate the potential usefulness of this strategy for the identification of immunogenic mutated-antigens. We propose that this approach would be of great help for the development of personalized cancer vaccine therapies in future.

9.
Gan To Kagaku Ryoho ; 43(Suppl 1): 11-13, 2016 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-28028267

RESUMEN

In order to strengthen the cooperation between medical and nursing care, Shinjuku Ward held a collaborative meeting for home care doctors and care managers in 2014. Because cooperation with the dentist was also necessary in elderly care from the viewpoint of eating deglutition and oral health care, Shinjuku Ward held a collaborative meeting for home care doctors, dentists, and care managers in 2015. A questionnaire was given to the participants, and almost all respondents answered "Helpful"when asked if the meeting was useful. Besides, all respondents answered that their"understanding of each other's areas and perspectives has deepened."Therefore, this collaborative meeting was suggested to promote cooperation and mutual understanding among doctors, dentists, and care managers.


Asunto(s)
Servicios de Atención de Salud a Domicilio , Grupo de Atención al Paciente , Gestores de Casos , Conducta Cooperativa , Odontólogos , Humanos , Japón , Médicos , Rol Profesional , Encuestas y Cuestionarios
10.
Angew Chem Int Ed Engl ; 53(26): 6624-7, 2014 Jun 23.
Artículo en Inglés | MEDLINE | ID: mdl-24719384

RESUMEN

Metal-mediated base pairs formed by the coordination of metal ions to natural or artificial bases impart unique chemical and physical properties to nucleic acids and have attracted considerable interest in the field of nanodevices. Ag(I) ions were found to mediate DNA polymerase catalyzed primer extension through the formation of a C-Ag(I)-T base pair, as well as the previously reported C-Ag(I)-A base pair. The comparative susceptibility of dNTPs to Ag(I)-mediated enzymatic incorporation into the site opposite cytosine in the template was shown to be dATP>dTTP≫dCTP. Furthermore, two kinds of metal ions, Ag(I) and Hg(II), selectively mediate the incorporation of thymidine 5'-triphosphate into sites opposite cytosine and thymine in the template, respectively. In other words, the regulated incorporation of different metal ions into programmed sites in the duplex by DNA polymerase was successfully achieved.


Asunto(s)
ADN Polimerasa Dirigida por ADN/metabolismo , Metales/química , Biocatálisis , ADN/química , ADN/metabolismo , ADN Polimerasa Dirigida por ADN/química , Iones/química , Metales/metabolismo , Conformación de Ácido Nucleico
12.
PLoS One ; 8(5): e62989, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23671647

RESUMEN

BACKGROUND: KRAS, BRAF and PIK3CA mutations are frequently observed in colorectal cancer (CRC). In particular, KRAS mutations are strong predictors for clinical outcomes of EGFR-targeted treatments such as cetuximab and panitumumab in metastatic colorectal cancer (mCRC). For mutation analysis, the current methods are time-consuming, and not readily available to all oncologists and pathologists. We have developed a novel, simple, sensitive and fully automated molecular diagnostic system (AMDS) for point of care testing (POCT). Here we report the results of a comparison study between AMDS and direct sequencing (DS) in the detection of KRAS, BRAF and PI3KCA somatic mutations. METHODOLOGY/PRINCIPAL FINDING: DNA was extracted from a slice of either frozen (n = 89) or formalin-fixed and paraffin-embedded (FFPE) CRC tissue (n = 70), and then used for mutation analysis by AMDS and DS. All mutations (n = 41 among frozen and 27 among FFPE samples) detected by DS were also successfully (100%) detected by the AMDS. However, 8 frozen and 6 FFPE samples detected as wild-type in the DS analysis were shown as mutants in the AMDS analysis. By cloning-sequencing assays, these discordant samples were confirmed as true mutants. One sample had simultaneous "hot spot" mutations of KRAS and PIK3CA, and cloning assay comfirmed that E542K and E545K were not on the same allele. Genotyping call rates for DS were 100.0% (89/89) and 74.3% (52/70) in frozen and FFPE samples, respectively, for the first attempt; whereas that of AMDS was 100.0% for both sample sets. For automated DNA extraction and mutation detection by AMDS, frozen tissues (n = 41) were successfully detected all mutations within 70 minutes. CONCLUSIONS/SIGNIFICANCE: AMDS has superior sensitivity and accuracy over DS, and is much easier to execute than conventional labor intensive manual mutation analysis. AMDS has great potential for POCT equipment for mutation analysis.


Asunto(s)
Neoplasias Colorrectales/diagnóstico , Neoplasias Colorrectales/genética , Mutación , Patología Molecular/métodos , Fosfatidilinositol 3-Quinasa Clase I , Análisis Mutacional de ADN/métodos , Formaldehído/química , Secciones por Congelación , Humanos , Adhesión en Parafina/métodos , Patología Molecular/instrumentación , Fosfatidilinositol 3-Quinasas/genética , Reacción en Cadena de la Polimerasa , Proteínas Proto-Oncogénicas B-raf/genética , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Fijación del Tejido/métodos , Proteínas ras/genética
14.
Biochem Biophys Res Commun ; 374(4): 699-703, 2008 Oct 03.
Artículo en Inglés | MEDLINE | ID: mdl-18680726

RESUMEN

Migration and tube formation of endothelial cells are important in angiogenesis and require a coordinated response to the extra-cellular matrix (ECM) and growth factor. Since focal adhesion kinase (FAK) integrates signals from both ECM and growth factor, we investigated its role in angiogenesis. Type I and II collagens are fibril-forming collagens and stimulate human umbilical vein endothelial cells (HUVECs) to form tube structure. Although knockdown of FAK restrained cell motility and resulted in inhibition of tube formation, FAK degradation and tube formation occurred simultaneously after incubation with fibril-forming collagens. The compensation for the FAK degradation by a calpain inhibitor or transient over-expression of FAK resulted in disturbance of tube formation. These phenomena are specific to fibril-forming collagens and mediated via alpha2beta1 integrin. In conclusion, our data indicate that FAK is functioning in cell migration, but fibril-forming collagen-induced FAK degradation is necessary for endothelial tube formation.


Asunto(s)
Movimiento Celular , Colágeno Tipo II/metabolismo , Colágeno Tipo I/metabolismo , Endotelio Vascular/crecimiento & desarrollo , Quinasa 1 de Adhesión Focal/metabolismo , Neovascularización Fisiológica , Animales , Células Cultivadas , Regulación hacia Abajo , Endotelio Vascular/citología , Quinasa 1 de Adhesión Focal/antagonistas & inhibidores , Geles , Humanos , Ratas
15.
J Colloid Interface Sci ; 310(2): 686-9, 2007 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-17382338

RESUMEN

We reported here that polyethylene glycol (PEG)-linked manganese pyrochlorophyllide a (PEG-MnPChlide a) possesses remarkable catalytic activity comparable to horseradish peroxidase (HRP). The PEG-MnPChlide a catalyzed the oxidation decoloration reaction of C.I. Acid Orange 7 by hydrogen peroxide under a mild aqueous condition, pH 8.0 at 25 degrees C. The manganese pyrochlorophyride a methylester (MnPChlide a ME) dissolved in a Triton X-100 micellar solution also exhibited the catalytic activity, indicating the micellar environment plays an important role in the catalytic reaction. The reaction rate was accelerated by addition of imidazole. The catalytic reactions were analyzed by Michaelis-Menten kinetics, revealing that the higher reactivity of catalyst-substrate complex is responsible for the present catalytic reaction system.


Asunto(s)
Compuestos Azo/química , Cloro/química , Colorantes/química , Manganeso/química , Peróxidos/química , Polietilenglicoles/química , Bencenosulfonatos , Catálisis , Peroxidasa de Rábano Silvestre/química , Concentración de Iones de Hidrógeno , Imidazoles/química , Octoxinol/química
16.
Chem Pharm Bull (Tokyo) ; 54(11): 1545-50, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17077551

RESUMEN

Three new cucurbitane-type triterpene called karavilagenins A, B, and C and five new cucurbitane-type triterpene glycosides called karavilosides I, II, III, IV, and V were isolated from the dried fruit of Sri Lanka Momordica charantia L. (Cucurbitaceae) together with two known cucurbitane-type triterpenes, 19(R)-methoxy-5beta,19-epoxycucurbita-6,23-dien-3beta,25-diol and 5,19-epoxycucurbita-6,23-diene-3,25-diol, and nine known cucurbitane-type triterpene glycosides, goyaglycosides-b, -c, and -d, and momordicosides F1, F2, G, I, K, and L. The structures of karavilagenins and karavilosides were elucidated on the basis of chemical and physicochemical evidence.


Asunto(s)
Frutas/química , Glicósidos/química , Momordica charantia/química , Triterpenos/química , Glicósidos/aislamiento & purificación , Conformación Molecular , Sri Lanka , Estereoisomerismo , Triterpenos/aislamiento & purificación
17.
J Endocrinol ; 191(2): 361-7, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17088405

RESUMEN

The biological effects of angiotensin II (AngII) are mediated by two major subtypes of AngII receptors, type 1 (AT1R) and type 2 (AT2R). In this study, we attempted to elucidate the role of AngII subtype receptor-specific regulation in migration and proliferation of mouse cultured mesangial (MSG) cells. We found that 100 nM AngII stimulated weak migration of MSG cells. Cell motility increased more in the presence of AT2R than in the presence of AT1R, and it was suppressed by guanylate cyclase inhibitors. On the other hand, the activation of AT1R resulted in increased cell numbers, while AT2R activation inhibited cell proliferation. Moreover, high concentrations of glucose (25 mM) stimulated the expression of AT2R but not AT1R. These results indicate that there are receptor subtype-specific roles in MSG cells, and it is therefore possible that the activation of AT2R stimulates repair of glomerular tissue defect, by regulation of migration and proliferation of MSG cells. Taken together, these results suggest that the relative concentrations of AT1R and AT2R are important factors in the regulation of AngII function in glomerular tissue, and alterations in the concentrations of these receptors may contribute to progression of or protection from diabetic nephropathy.


Asunto(s)
Angiotensina II/farmacología , Células Mesangiales/citología , Receptores de Angiotensina/metabolismo , Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología , Bloqueadores del Receptor Tipo 2 de Angiotensina II , Antagonistas de Receptores de Angiotensina , Animales , Unión Competitiva , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Imidazoles/farmacología , Immunoblotting , Células Mesangiales/efectos de los fármacos , Células Mesangiales/metabolismo , Ratones , Piridinas/farmacología , Receptor de Angiotensina Tipo 1/metabolismo , Receptor de Angiotensina Tipo 2/metabolismo , Tetrazoles/farmacología
18.
J Biol Chem ; 279(53): 55104-8, 2004 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-15494412

RESUMEN

Because vascular endothelial cell growth factor (VEGF) and transforming growth factor-beta (TGF-beta) are both involved in cellular growth and differentiation, we examined whether VEGF modifies TGF-beta signaling cascade in human umbilical cord vein endothelial cells (HUVEC). Production of plasminogen activator inhibitor-1 (PAI-1), which is under the specific control of TGF-beta, was strongly enhanced (3.5-fold) by TGF-beta treatment. Remarkably, physiological concentration of VEGF (30 nm) profoundly (by 60%) attenuated the TGF-beta stimulation of PAI-1 production without an effect on the basal PAI-1 production. In HUVECs transiently transfected with an expression construct containing a PAI-1 promoter fused to luciferase reporter gene, TGF-beta-stimulation of transcription of PAI-1 was clearly (by 60%) inhibited by VEGF. TGF-beta phosphorylation of Smad2/3, an obligatory step of intracellular TGF-beta signaling, was also suppressed by VEGF. VEGF attenuation of TGF-beta action was also demonstrated in two other endothelial cell lines. In conclusion, VEGF attenuates TGF-beta action in the human endothelial cell, specifically at the level of transcription of PAI-1 gene and Smad2/3 phosphorylation.


Asunto(s)
Endotelio Vascular/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Factor A de Crecimiento Endotelial Vascular/fisiología , Androstadienos/farmacología , Western Blotting , Línea Celular , Células Cultivadas , Proteínas de Unión al ADN/metabolismo , Relación Dosis-Respuesta a Droga , Endotelio Vascular/citología , Genes Reporteros , Humanos , Immunoblotting , Inmunoprecipitación , Luciferasas/metabolismo , Fosforilación , Plásmidos/metabolismo , Inhibidor 1 de Activador Plasminogénico/biosíntesis , Regiones Promotoras Genéticas , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Recombinantes/química , Transducción de Señal , Proteína Smad2 , Proteína smad3 , Factores de Tiempo , Transactivadores/metabolismo , Transcripción Genética , Transfección , Cordón Umbilical/citología , Factor A de Crecimiento Endotelial Vascular/metabolismo , Wortmanina
19.
Curr Ther Res Clin Exp ; 64(2): 81-94, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24944358

RESUMEN

BACKGROUND: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) have been used to treat congestive heart failure (CHF). According to a MEDLINE search, however, few studies are available on the clinical differences between ARBs and ACEIs in CHF. OBJECTIVE: To examine the clinical differences between an ARB (candesartan cilexetil) and an ACEI (lisinopril) in the treatment of CHF, we investigated exercise capacity, ventricular function, and neurohormonal levels in hypertensive patients with CHF before and after treatment with these agents. METHODS: Patients with symptoms of CHF (New York Heart Association functional class II-III and left ventricular ejection fraction [LVEF] ≤45%) complicated by hypertension (systolic blood pressure [BP] ≥140 mm Hg or diastolic BP ≥90 mm Hg) were eligible for this single-center, open-label, randomized, parallel-group study. They were given either the ARB or the ACEI for 24 weeks. A cardiopulmonary exercise test and echocardiography were performed. Clinical findings and cardiac events in addition to the CHF symptoms were investigated. Neurohormonal levels were measured before and after 24 weeks of treatment with the study drug. The primary end point of this study was exercise capacity, which was measured using peak oxygen consumption (VO2). RESULTS: Forty-two patients with CHF were enrolled and 38 (28 men, 10 women; mean [SD] age, 69.0 [8.2] years) completed the study. None of these patients had definite progression of the CHF symptoms. In the ARB-treated patients, mean (SD) peak VO2 (mL/min/kg) and LVEF (%) increased from 14.1 (2.9) to 15.3 (3.4) and from 34.4 (9.5) to 41.8 (9.5), respectively. In the ACEI group, the peak VO2 did not change, but the LVEF (%) increased from 34.2 (10.2) to 40.4 (13.0). However, the differences between ARB and ACEI were not clarified because of the possibility of a small sample size. CONCLUSIONS: Although this study was not powered to show differences in efficacy between the ARB and ACEI in this study, our findings suggest that both ARB and ACEI had beneficial effects in hypertensive patients with CHF. Some unidentified differences in hemodynamic characteristics were found between the ARB and the ACEI groups.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...